BRAF and cutaneous mastocytosis: Furthermore, there is a lack of studies regarding the influence of BRAF mutations on survival in early-stage CM, raising questions about whether early-stage patients might benefit from BRAF mutational testing to better guide follow-up strategies and personalize their care (46).